Ryan Craig, MD, PhD
Assistant Professor
Education & Affiliations
Biography
Ryan Craig, originally from Baton Rouge, LA, graduated from Louisiana State University Health Sciences Center - School of Medicine in New Orleans, where he developed a strong interest in pathology and specifically hematopathology. Ryan completed his AP/CP residency and hematopathology fellowship training at University of Utah in Salt Lake City. He currently serves as Program Director for the Pathology Residency Program at Tulane University School of Medicine. In his personal time, Ryan enjoys traveling, photography, and participating in most sports. His favorite restaurant in New Orleans is Coquette, although he finds it difficult to choose just one.
Ryan chose to teach at Tulane because he wanted to be in New Orleans, closer to family, and was drawn to Tulane’s hematopathology program. He believes New Orleans is the greatest city in the world, offering numerous fun activities throughout the year.
Appointment and Position
2020-present Module Co-Director for Phase I Fundamentals of Human Biology (Tulane School of Medicine)
2020-present Module Co-Director for Phase II Mechanisms of Disease (Tulane School of Medicine)
2020-present Pathology Clerkship Director/Pathology Career Advisor for Medical Students
2019-present Assistant Program Director for AP/CP Pathology Residency
2019-present Assistant Medical Director of Clinical Chemistry
2019-present Assistant Professor of Pathology, Tulane University School of Medicine
Contributions
Pincus, S.; Craig, R.; Weachter, L.; LaBranche, C.; Nabi, R.; Watt, C.; Raymond, M.; Peters, T.; Song, K.; Maresh, G.; Montefiori, D.; Kozlowski, P. Bispecific Anti-HIV Immunoadhesins That Bind gp120 and gp41 Have Broad and Potent HIV-Neutralizing Activity. Vaccines 2021, 9(7), 774.
Ibrahim M, Chen R, Vegel A, Panse K, Bhyravabhotla K, Harris K, Craig R, Safah H, Saba NS, Socola F. 2021. Treatment of myeloid sarcoma without bone marrow involvement with gemtuzumab ozogamicin-containing regimen. Leuk Res. 2021 April 22;106:106583
Craig RB, Summa CM, Corti M, Pincus SH. 2012. Anti-HIV double variable domain immunoglobulins binding both gp41 and gp120 for targeted delivery of immunoconjugates. PLoS One, 2012;7(10):e46778
Craig R, Cutrera J, Zhu S, Xia X, Lee YH, Li S. 2008. Administering plasmid DNA encoding tumor vessel-anchored IFN-alpha for localizing gene product within on into tumors. Molecular Therapy, 2008 May;16(5):901-6.
Craig R, Li S. 2006. Function and molecular mechanisms of tumor-targeted peptides for delivering therapeutic genes and chemical drugs. Mini Reviews in Medicinal Chemistry, 2006 Jul;6(7):757-64.
